45 studies found for:    "Focal segmental glomerulosclerosis"
Show Display Options
Rank Status Study
1 Terminated Safety and Pharmacokinetics of FG-3019 in Adolescents and Adults With Focal Segmental Glomerulosclerosis (FSGS)
Condition: Focal Segmental Glomerulosclerosis
Intervention: Drug: FG-3019
2 Completed Prednisone Plus Tripterygium Wilfordii Treatment of Adult Patients With Idiopathic Focal Segmental Glomerulosclerosis
Conditions: Proteinuria;   Focal Segmental Glomerulosclerosis
Intervention: Drug: tripterygium wilfordii (TW)
3 Unknown  Therapeutic Effect of Low-dose Prednisone Combined With MMF and FK506 in Focal Segmental Glomerulosclerosis
Condition: Focal Segmental Glomerulosclerosis
Interventions: Drug: prednisone, FK506, MMF;   Drug: prednisone
4 Completed Rituximab Treatment of Focal Segmental Glomerulosclerosis
Condition: Focal Segmental Glomerulosclerosis (FSGS)
Intervention: Drug: rituximab
5 Completed Permeability Factor in Focal Segmental Glomerulosclerosis
Condition: Focal Segmental Glomerulosclerosis
Interventions: Procedure: Plasma exchange;   Drug: Cyclophosphamide
6 Terminated Cardiomyopathy in Steroid-resistant Nephrotic Syndrome: Impact of Focal Segmental Glomerulosclerosis
Conditions: Focal Segmental Glomerulosclerosis;   Nephrotic Syndrome;   Steroid Resistant Nephrotic Syndrome;   Chronic Kidney Disease
Interventions: Other: Cardiovascular Assessment;   Other: Renal Assessment;   Other: Genetic Evaluation
7 Terminated Effect of Oral Galactose on Focal Segmental Glomerulosclerosis (FSGS) Permeability Factor
Condition: Focal Segmental Glomerulosclerosis
Intervention: Drug: Galactose
8 Recruiting Randomized, Double-Blind, Safety and Efficacy Study of RE-021 (Sparsentan) in Focal Segmental Glomerulosclerosis
Condition: Focal Segmental Glomerulosclerosis
Interventions: Drug: RE-021 (Sparsentan);   Drug: Irbesartan
9 Withdrawn A Study of RE-021 in Patients With Focal Segmental Glomerulosclerosis
Condition: Primary Focal Segmental Glomerulosclerosis
Intervention: Drug: RE-021
10 Completed Safety Study of GC1008 in Patients With Focal Segmental Glomerulosclerosis (FSGS) of Single Doses of GC1008 in Patients With Treatment Resistant Idiopathic FSGS
Condition: Focal Segmental Glomerulosclerosis
Intervention: Biological: GC1008
11 Active, not recruiting A Study of Fresolimumab in Patients With Steroid-Resistant Primary Focal Segmental Glomerulosclerosis (FSGS)
Condition: Primary Focal Segmental Glomerulosclerosis
Interventions: Drug: fresolimumab;   Drug: Placebo
12 Not yet recruiting Post Approval Study of Liposorber LA-15 System for the Treatment of Focal Segmental Glomerulosclerosis in Children
Condition: Focal Segmental Glomerulosclerosis 1
Intervention: Device: Liposorber® LA-15 System
13 Completed Sirolimus for Focal Segmental Glomerulosclerosis
Condition: Focal Glomerulosclerosis
Intervention: Drug: Sirolimus
14 Completed Focal Segmental Glomerulosclerosis Clinical Trial (FSGS-CT)
Condition: Glomerulosclerosis, Focal
Interventions: Drug: Cyclosporin;   Drug: MMF and Dexamethasone
15 Completed
Has Results
Pirfenidone to Treat Kidney Disease (Focal Segmental Glomerulosclerosis)
Conditions: Fibrosis;   Focal Glomerulosclerosis;   Kidney Failure;   Nephrotic Syndrome;   Proteinuria
Intervention: Drug: Pirfenidone
16 Recruiting A Phase II, Repeat Dose, Proof of Mechanism Study of Losmapimod to Reduce Proteinuria in Patients With Focal Segmental Glomerulosclerosis (FSGS)
Condition: Glomerulosclerosis, Focal Segmental
Intervention: Drug: Losmapimod
17 Recruiting Genetic Markers for Focal Segmental Glomerulosclerosis
Conditions: AIDS Associated Nephropathy;   Focal Glomerulosclerosis;   HIV Infections
Intervention:
18 Suspended Effect of Galactose on Permeblity Factor in Patients With FSGS and CKD Stage 5
Condition: Focal Segmental Glomerulosclerosis
Intervention: Drug: Galactose
19 Active, not recruiting A Pilot Study to Assess the Efficacy of Rituximab Therapy in Treatment Resistant FSGS
Condition: Primary Focal Segmental Glomerulosclerosis
Intervention: Biological: Rituximab
20 Withdrawn Tacrolimus Treatment of Patients With Idiopathic Focal Segmental Glomerulosclerosis
Condition: Focal Glomerulosclerosis
Intervention: Drug: Tacrolimus

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years